Commentary on 'glucocorticoids for the treatment of anaphylaxis'

Alexandra F Santos1, Gideon Lack

  • 1Department of Pediatric Allergy, Division of Asthma, Allergy & Lung Biology, King's College London-MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK. alexandra.santos@kcl.ac.uk

Insights

Glucocorticoids may not be effective in treating anaphylaxis, according to a commentary on a Cochrane review. Further research is needed to confirm the role of these steroids in managing severe allergic reactions.

Area of Science:

  • Anaphylaxis Management
  • Pharmacology
  • Allergy and Immunology

Background:

  • Anaphylaxis is a severe, life-threatening allergic reaction.
  • Glucocorticoids are often used as adjunctive therapy for anaphylaxis.
  • The efficacy of glucocorticoids in anaphylaxis treatment remains debated.

Purpose of the Study:

  • To critically evaluate the evidence for glucocorticoid use in anaphylaxis.
  • To discuss the implications of the Cochrane review findings for clinical practice.

Main Methods:

  • Commentary based on a systematic review of randomized controlled trials.
  • Analysis of data regarding the effectiveness and safety of glucocorticoids.

Main Results:

  • The Cochrane review found insufficient evidence to support the routine use of glucocorticoids in anaphylaxis.
  • Glucocorticoids did not appear to reduce the risk of biphasic or prolonged reactions.

Conclusions:

  • Current evidence does not support the routine administration of glucocorticoids for anaphylaxis.
  • Further high-quality research is necessary to clarify the role of glucocorticoids in anaphylaxis management.

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions02:06

Allergic Reactions

Overview
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...